EDGAR Filing Documents for 0000000000-20-003129

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-20-003129

Filing Date

2020-04-10

Accepted

2020-04-10 13:31:24

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	27611
2		filename2.txt	TEXT-EXTRACT	1219
	Complete submission text file	0000000000-20-003129.txt		39945

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filed for) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances